| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.35 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |